Similarly, in ovarian cancer, platelet release promotes the formation of tumor spheroids with high expression of tumor stem cell markers such as CD133 and aldehyde dehydrogenase (ALDH), which show resistance to cell death induced by cisplatin, carboplatin, and paclitaxel [146]. This evidence concerns the gene PROM1 and neoplasm.